These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 19564185)

  • 21. Do statins lower blood pressure?
    Mangat S; Agarwal S; Rosendorff C
    J Cardiovasc Pharmacol Ther; 2007 Jun; 12(2):112-23. PubMed ID: 17562781
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of seven different modalities of antihypertensive therapy on pulse pressure in patients with newly diagnosed stage I hypertension.
    Alici G; Aliyev F; Bellur G; Okcun B; Türkoğlu C; Karpuz H
    Cardiovasc Ther; 2009; 27(1):4-9. PubMed ID: 19207474
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Higher small arterial elasticity in hypertensive patients treated with angiotensin II receptor blockers.
    Takeuchi K; Ideishi M; Tashiro T; Morishige N; Yamada T; Saku K; Urata H
    Hypertens Res; 2005 Aug; 28(8):639-44. PubMed ID: 16392767
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment for dyslipidemias in patients with arterial hypertension].
    Chazova IE; Kukharchuk VV; Ratova LG; Kaminnaia VI
    Ter Arkh; 2007; 79(4):53-7. PubMed ID: 17564020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blood pressure-lowering drugs not considered as antihypertensives.
    Nilsson PM
    Curr Hypertens Rep; 2007 Aug; 9(4):249-50. PubMed ID: 17686371
    [No Abstract]   [Full Text] [Related]  

  • 26. [ALLHAT].
    Ando K
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():402-7. PubMed ID: 16981570
    [No Abstract]   [Full Text] [Related]  

  • 27. The editor's roundtable: Acute decompensated heart failure.
    Friedewald VE; Gheorghiade M; Yancy CW; Young JB; Roberts WC
    Am J Cardiol; 2007 Jun; 99(11):1560-7. PubMed ID: 17531581
    [No Abstract]   [Full Text] [Related]  

  • 28. Risk stratification for the prevention of cardiovascular complications of hypertension.
    Girerd X; Giral P
    Curr Med Res Opin; 2004 Jul; 20(7):1137-42. PubMed ID: 15265258
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cholesterol--frequently asked questions.
    Phillips PJ; Phillipov G
    Aust Fam Physician; 2006 Aug; 35(8):595-6. PubMed ID: 16894432
    [No Abstract]   [Full Text] [Related]  

  • 30. The management of hypertension in ischaemic heart disease.
    Hawkins NM; Dunn FG
    Curr Opin Cardiol; 2006 Jul; 21(4):273-8. PubMed ID: 16755194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term effects of Xuezhikang on blood pressure in hypertensive patients with previous myocardial infarction: data from the Chinese Coronary Secondary Prevention Study (CCSPS).
    Li JJ; Lu ZL; Kou WR; Chen Z; Wu YF; Yu XH; Zhao YC;
    Clin Exp Hypertens; 2010; 32(8):491-8. PubMed ID: 21091365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Results of a Markov model analysis to assess the cost-effectiveness of a single tablet of fixed-dose amlodipine and atorvastatin for the primary prevention of cardiovascular disease in Korea.
    Liew D; Park HJ; Ko SK
    Clin Ther; 2009 Oct; 31(10):2189-203; discussion 2150-1. PubMed ID: 19922890
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does life-long reduction in low-density lipoprotein cholesterol reduce the risk of new-onset hypertension?
    Messerli FH; Bangalore S; Egan BM; Julius S
    Am J Cardiol; 2006 Oct; 98(8):1122. PubMed ID: 17027588
    [No Abstract]   [Full Text] [Related]  

  • 34. Statins: another class of antihypertensive agents?
    Milionis HJ; Liberopoulos EN; Achimastos A; Elisaf MS; Mikhailidis DP
    J Hum Hypertens; 2006 May; 20(5):320-35. PubMed ID: 16511505
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Statin effects in CKD: is there a "point of no return"?
    Wanner C
    Am J Kidney Dis; 2009 May; 53(5):723-5. PubMed ID: 19393469
    [No Abstract]   [Full Text] [Related]  

  • 36. [High blood pressure and coronary heart disease. Are there new therapeutic options?].
    Motz W
    Herz; 2004 May; 29(3):255-65. PubMed ID: 15167951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting low-density lipoprotein cholesterol in cardiovascular health.
    Spratt KA
    J Am Osteopath Assoc; 2010 Apr; 110(4 Suppl 4):Sii-S1. PubMed ID: 20496459
    [No Abstract]   [Full Text] [Related]  

  • 38. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.
    Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):e149-61. PubMed ID: 15297292
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.
    Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
    J Am Coll Cardiol; 2004 Aug; 44(3):720-32. PubMed ID: 15358046
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Physician support for a population-based pharmaceutical approach to cardiovascular prevention: not there yet.
    Huy C; Litaker D
    Prev Med; 2011 Jan; 52(1):18-9. PubMed ID: 21130110
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.